Leadership

Executive Team

Jon Williams MBA Chief Executive Officer

Rebecca Hyde Chief Operating Officer and Global Practice Lead, Value Access and Outcomes

Jane Shirley Global Practice Lead, Asset Optimization & Commercialization

Gema Parlange, Chief Commercial and Development Officer at Lumanity

Gema Parlange MBA, MEcon Chief Commercial and Development Officer, and Global Practice Lead, Real World Evidence

Michael Parisi MBA Global Practice Lead, Medical Strategy & Communications

Mark Bentley Chief Financial Officer

Jordan Cohen MBA, MHA Chief People Officer

Sarah Martin MBA Senior Vice President, Corporate Development

Strategic Advisory Board

Ron Akehurst, Executive Chairman at Lumanity

Ron Akehurst BSc, DSc, MFPH Executive Chair, HEOR

Muna Bhanji R.Ph. Founder and President, Tiba Global Access LLC

Diana Brixner RPH, PhD, FAMCP Professor, Pharmacotherapy and Executive Director, Pharmacotherapy Outcomes Research Center, University of Utah

Gillian Cannon PhD Chief Operating Officer, Alyvant

Aree Cheshire PhD Vice President, Client Strategy, Communications

Peg Crowley-Nowick PhD, MBA President, Medical Affairs Consulting and Head of Medical Affairs

Kimberly Dittmar, VP, Medical Services at Lumanity

Kimberly Dittmar PhD, CMPPTM VP, Medical Services

Andrew Dreyfus President and CEO, Blue Cross Blue Shield of Massachusetts

Sébastien Genève Senior Vice President, Regulatory

Denis Getsios Senior Vice President, Scientific Strategy and Applications

Amber Gilbert MBA Global President, Market Access

Dan Gladwell PhD Chief of HTA Strategy, HEOR

Gene Gorbach MBA Investment Partner, Arsenal Capital Partners

Mary Harney Independent Director and Business Adviser

Claes W. Hornstrand President and CEO of Wildwood Therapeutics, Inc.

Mark McClellan MD, PhD Director and Robert J. Margolis, M.D., Professor of Business, Medicine and Policy at the Margolis Center for Health Policy at Duke University

Julia Ralston, Chief Business Officer and Global Practice Lead, Medical Strategy & Communications at Lumanity

Julia Ralston Special Advisor to the CEO and Board

Edward C. Saltzman Senior Strategic Advisor

Joel Sandler, Principal, Head of Cancer Cell Therapy Practice at Lumanity

Joel Sandler PhD Principal, BioConsulting, Cancer Cell Therapy Lead, Central Nervous System Co-Lead

Betül Susamis Unaran Chief Commercial Officer, Executive Leadership, Unilabs

Jürgen Wasem PhD Chairperson bei Arbitration Board Fees for Digital Health Apps in Social Health Insurance, National Level

Burt Zweigenhaft PhD Managing Partner of Upstream-Partners, LLC

Lumanity Board

Mike Bernstein J.D. Operating Partner, Arsenal Capital Partners

Muna Bhanji R.Ph. Founder and President, Tiba Global Access LLC

Gene Gorbach MBA Investment Partner, Arsenal Capital Partners

Taylor Holland Vice President, Arsenal Capital Partners

Rich Pilnik MBA Chairman of the Board, DiaMedica Therapeutics Inc.

Pascale Witz MSc, MBA Founder and President of PWH Advisors LLC, and Chairwoman of RTI Surgical, Inc.